Author

Eveline M. Dijkgraaf

Observed names: E M Dijkgraaf, E. M. Dijkgraaf, E.M. Dijkgraaf, EM Dijkgraaf

Observed institutions: Leiden University, Leiden University Medical Center

OpenAlex ID: A5111698837

Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2013 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al. · Cancer Research · 364

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

2015 · Saskia J. A. M. Santegoets, Eveline M. Dijkgraaf, et al. · Cancer Immunology Immunotherapy · 228

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

2015 · E.M. Dijkgraaf, S.J.A.M. Santegoets, et al. · Annals of Oncology · 202

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer

2015 · Eveline M. Dijkgraaf, Saskia J.A.M. Santegoets, et al. · Oncotarget · 84

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

2012 · Eveline M. Dijkgraaf, Marij J.P. Welters, et al. · Current Pharmaceutical Design · 67

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival

2018 · S. J. A. M. Santegoets, A. F. de Groot, et al. · OncoImmunology · 45

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer

2014 · MCA Wouters, EM Dijkgraaf, et al. · OncoImmunology · 32

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

2015 · S. de Groot, L. G. M. Janssen, et al. · Breast Cancer Research and Treatment · 30

Effect of Hypoxic Stress on Migration and Characteristics of Monocytes in Uveal Melanoma

2014 · Inge H. G. Bronkhorst, Tina M. L. Jehs, et al. · JAMA Ophthalmology · 29

Supplementary Figure 2 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Supplementary Table 1 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Supplementary Figure 1 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Supplementary Methods from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Supplementary Table 2 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Supplementary Figure 3 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Supplementary Figure 4 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Data from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment

2023 · Eveline M. Dijkgraaf, Moniek Heusinkveld, et al.

Immune-based therapies in ovarian cancer

2017 · E. M. Dijkgraaf · Leiden Repository (Leiden University)

Abstract P3-06-50: Thyroid function is associated with the response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial on behalf of the Dutch Breast Cancer Research Group (BOOG 2010-01)

2015 · S de Groot, A Charehbili, et al. · Cancer Research

Abstract 4712: Chemotherapy-enhanced NFkB pathway activation in gynecological cancers increases the differentiation of monocytes to M2 macrophages instead of dendritic cells.

2013 · Sjoerd H. Van Der Burg, Eveline M. Dijkgraaf, et al. · Cancer Research

Works count: 20

Citation count: 1,081

H-index: 9

I10-index: 9